clinical trial · NCT04408599
A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors
Advanced or Metastatic Solid TumorsOvarian CancerGastric CancerColo-rectal CancerNC410
brief summary
This research study is studying a new drug, NC410, as a possible treatment for advanced or metastatic solid tumors.
started
Jun 10, 2020
primary completion
Jul 6, 2023
completion
Jul 6, 2023
last updated
Jul 25, 2024
official title
A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol